Heba Jalil is an associate in the London Life Sciences practice group. She has acted for pharmaceutical companies in relation to a range of litigation and regulatory matters, including public inquiries regarding medicinal products and product liability litigation before the UK courts.
Ms. Jalil assists with commercial transactions involved in the development and commercialisation of medicinal products, with particular experience in drafting and negotiating supply and distribution agreements.
As well as her Life Sciences practice, she is committed to pro bono work and has represented clients in matters of immigration and in relation to welfare benefits.
Perspectives
March 6, 2026
Provisional text of the political agreement on the reform to the EU Regulatory Framework for Medicinal Products is published
BioSlice Blog
November 18, 2025
Can a chemically synthesised medicine be authorised as a generic of a biological medicine? And who can challenge this?
BioSlice Blog
July 29, 2025
Updates to the EU Pharmacovigilance Rules: Key Takeaways for Marketing Authorisation Holders
BioSlice Blog
July 24, 2025
The UK Government has Plans: What Does This Mean for the Life Sciences Sector?
BioSlice Blog
More
Credentials
Education
- Legal Practice Course, The University of Law, 2022
- B.A., Jurisprudence (Law), University of Oxford, 2020
Admissions
- England and Wales